Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Biocon Biologics Inc.

NDC labeler code: 83257

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

20Products (NDC)

FDA applications for these products

  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
September 16, 2025BLA761436 Denosumab
AUKELSO, BOSAYA
Biocon Biologics Inc
July 15, 2025BLA761188 Insulin aspart, Water
KIRSTY
Biocon Biologics Inc
April 9, 2025BLA761175 Bevacizumab
JOBEVNE
Biocon Biologics Inc
November 29, 2024BLA761406 Ustekinumab
YESINTEK
Biocon Biologics Inc
May 20, 2024BLA761274 Aflibercept
YESAFILI
Biocon Biologics Inc
July 28, 2021BLA761201 Insulin glargine
SEMGLEE
Mylan Pharms Inc
June 4, 2018BLA761075 Pegfilgrastim-cbqv
FULPHILA
Mylan GmbH
December 1, 2017BLA761074 Trastuzumab
OGIVRI
Mylan GmbH

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

No recall of these products (by NDC code) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →